Surgery Partners, Inc. Common Stock

SGRY

Surgery Partners, Inc. (SGRY) is a healthcare company that provides outpatient surgical services through a network of surgical facilities across the United States. The company focuses on delivering specialized procedures in areas such as outpatient surgery, endoscopy, pain management, and other ambulatory care services, aiming to improve patient outcomes and streamline healthcare delivery.

$17.25 +0.06 (0.38%)
🚫 Surgery Partners, Inc. Common Stock does not pay dividends

Company News

AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board
GlobeNewswire Inc. • Yogi Jashnani • November 17, 2025

AirSculpt Technologies appointed Mike Doyle as Non-Executive Chairman of its Board of Directors. Doyle brings over 30 years of leadership experience in multi-center healthcare and has previously led Surgery Partners and founded MD Healthcare Partners.

Why Surgery Partners Stock Plummeted on Monday
The Motley Fool • Eric Volkman • November 10, 2025

Surgery Partners experienced a significant stock drop of nearly 25% after reporting Q3 earnings that missed analyst expectations, with lower-than-anticipated non-GAAP earnings and revenue, despite a 7% year-over-year revenue growth.

Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
Benzinga • Globe Newswire • January 28, 2025

Surgery Partners, Inc. has received a non-binding acquisition proposal from Bain Capital to acquire all outstanding shares not already owned by Bain Capital for $25.75 per share. A special committee of independent directors will consider the proposal with the assistance of advisors.

After-hours movers: Netflix, Intuitive Surgical, and more By Investing.com - Investing.com Canada
Investing.com • Louis Juricic • July 18, 2024

Netflix reported mixed Q2 results, with better-than-expected earnings but weaker guidance. Intuitive Surgical saw strong Q2 results, with a 17% increase in procedures. Plug Power announced a $200 million stock offering, while Surgery Partners is exploring strategic options including a potential sale.

Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock?
Zacks Investment Research • Zacks Equity Research • June 25, 2024

Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Related Companies